FTRE Projected Dividend Yield

Fortrea Holdings Inc ( NASDAQ : FTRE )

Fortrea Holdings is a contract research organization providing phase I through IV biopharmaceutical product and medical device services, patient access solutions and other services. Co. provides its pharmaceutical, biotechnology, and medical device customers with clinical pharmacology, clinical development, and other service capabilities. Co. manages its business in two segments: Clinical Services, which brings solutions to market which include clinical pharmacology and clinical development capabilities; as well as Enabling Services, which provides patient access and technology solutions which can be deployed across any of its global solutions depending on the scope of its customers' needs.

20 YEAR PERFORMANCE RESULTS